Cargando…

T cell‐dependent bispecific antibodies alter organ‐specific endothelial cell–T cell interaction

Preclinical and clinical studies demonstrate that T cell‐dependent bispecific antibodies (TDBs) induce systemic changes in addition to tumor killing, leading to adverse events. Here, we report an in‐depth characterization of acute responses to TDBs in tumor‐bearing mice. Contrary to modest changes i...

Descripción completa

Detalles Bibliográficos
Autores principales:	Himmels, Patricia, Nguyen, Thi Thu Thao, Mitzner, Maresa Caunt, Arrazate, Alfonso, Yeung, Stacey, Burton, Jeremy, Clark, Robyn, Totpal, Klara, Jesudason, Raj, Yang, Angela, Solon, Margaret, Eastham, Jeffrey, Modrusan, Zora, Webster, Joshua D, Lo, Amy A, Piskol, Robert, Ye, Weilan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2023
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9986820/ https://www.ncbi.nlm.nih.gov/pubmed/36621885 http://dx.doi.org/10.15252/embr.202255532

Ejemplares similares

Novel Anti-LY6G6D/CD3 T-Cell–Dependent Bispecific Antibody for the Treatment of Colorectal Cancer
por: Wang, Peiyin, et al.
Publicado: (2022)

Disruption of stem cell niche–confined R-spondin 3 expression leads to impaired hematopoiesis
por: Kurtova, Antonina V., et al.
Publicado: (2022)

Inhibition of VEGF-C Modulates Distal Lymphatic Remodeling and Secondary Metastasis
por: Gogineni, Alvin, et al.
Publicado: (2013)

NRG1 is a critical regulator of differentiation in TP63-driven squamous cell carcinoma
por: Hegde, Ganapati V, et al.
Publicado: (2019)

Bispecific, T-Cell-Recruiting Antibodies in B-Cell Malignancies
por: Lejeune, Margaux, et al.
Publicado: (2020)

For whom the T cells troll? Bispecific T-cell engagers in glioblastoma
por: Singh, Kirit, et al.
Publicado: (2021)

Functional characterization of SMARCA4 variants identified by targeted exome-sequencing of 131,668 cancer patients
por: Fernando, Tharu M., et al.
Publicado: (2020)

Quantification of cell surface proteins with bispecific antibodies
por: Panke, C., et al.
Publicado: (2013)

Editorial: Bispecific Antibodies for T-Cell Based Immunotherapy
por: Santich, Brian H., et al.
Publicado: (2020)

The landscape of bispecific T cell engager in cancer treatment
por: Zhou, Shujie, et al.
Publicado: (2021)

The race is on: bispecifics vs CAR T cells in B-cell lymphoma
por: Gurumurthi, Ashwath, et al.
Publicado: (2023)

EHMT2 methyltransferase governs cell identity in the lung and is required for KRAS (G12D) tumor development and propagation
por: Pribluda, Ariel, et al.
Publicado: (2022)

Single-cell RNA sequencing identifies distinct mouse medial ganglionic eminence cell types
por: Chen, Ying-Jiun J., et al.
Publicado: (2017)

Biomarkers of Residual Disease, Disseminated Tumor Cells, and Metastases in the MMTV-PyMT Breast Cancer Model
por: Franci, Christian, et al.
Publicado: (2013)

The role of apoptosis in bispecific antibody-mediated T-cell cytotoxicity.
por: Kroesen, B. J., et al.
Publicado: (1996)

Enhancing the antitumor potency of T cells redirected by bispecific antibodies
por: Chang, Chien-Hsing, et al.
Publicado: (2017)

Pharmacokinetics and Pharmacodynamics of T-Cell Bispecifics in the Tumour Interstitial Fluid
por: Eigenmann, Miro Julian, et al.
Publicado: (2021)

Bispecific T-Cell Engagers and Chimeric Antigen Receptor T-Cell Therapies in Glioblastoma: An Update
por: Alsajjan, Roa, et al.
Publicado: (2023)

Targeting and killing of glioblastoma with activated T cells armed with bispecific antibodies
por: Zitron, Ian M, et al.
Publicado: (2013)

Ipilimumab augments antitumor activity of bispecific antibody-armed T cells
por: Yano, Hiroshi, et al.
Publicado: (2014)

Therapeutic Bispecific T-Cell Engager Antibody Targeting the Transferrin Receptor
por: Fu, Mingpeng, et al.
Publicado: (2019)

Influence of the bispecific antibody IgG subclass on T cell redirection
por: Kapelski, Stephanie, et al.
Publicado: (2019)

Overcoming leukemia heterogeneity by combining T cell engaging bispecific antibodies
por: Hoseini, Sayed Shahabuddin, et al.
Publicado: (2020)

Bispecific T-Cell Engagers Targeting Membrane-Bound IgE
por: Rodak, Aleksandra, et al.
Publicado: (2021)

Platelets subvert antitumor efficacy of T cell-recruiting bispecific antibodies
por: Lutz, Martina Svenja, et al.
Publicado: (2022)

Bispecific T cell engagers: an emerging therapy for management of hematologic malignancies
por: Tian, Zheng, et al.
Publicado: (2021)

Dichotomous impact of affinity on the function of T cell engaging bispecific antibodies
por: Poussin, Mathilde, et al.
Publicado: (2021)

Bispecific Antibody Armed Metabolically Enhanced Headless CAR T Cells
por: Thakur, Archana, et al.
Publicado: (2021)

Bispecific T Cell Engagers for the Treatment of Multiple Myeloma: Achievements and Challenges
por: Alhallak, Kinan, et al.
Publicado: (2021)

Bispecific Antibody-Bound T Cells as a Novel Anticancer Immunotherapy
por: Cho, Jaewon, et al.
Publicado: (2022)

Bispecific antibody-targeted T-cell therapy for acute myeloid leukemia
por: Kubicka, Ewa, et al.
Publicado: (2022)

Labeling Cell Surface Receptors with Ligand.BirA* Bispecifics
por: Alwash, Mays, et al.
Publicado: (2022)

Combination therapies for the optimisation of Bispecific T-cell Engagers in cancer treatment
por: Zhu, Winston M, et al.
Publicado: (2023)

Simultaneous Multiple Interaction T-cell Engaging (SMITE) Bispecific Antibodies Overcome Bispecific T-cell Engager (BiTE) Resistance Via CD28 Co-Stimulation
por: Correnti, Colin E., et al.
Publicado: (2018)

Development of a bioassay to detect T-cell-activating impurities for T-cell-dependent bispecific antibodies
por: Lee, Ho Young, et al.
Publicado: (2019)

Bispecific Chimeric Antigen Receptor T Cell Therapy for B Cell Malignancies and Multiple Myeloma
por: Cronk, Robert J., et al.
Publicado: (2020)

Engineering Immune Cells for in vivo Secretion of Tumor-Specific T Cell-Redirecting Bispecific Antibodies
por: Blanco, Belén, et al.
Publicado: (2020)

Therapeutic afucosylated monoclonal antibody and bispecific T-cell engagers for T-cell acute lymphoblastic leukemia
por: Caracciolo, Daniele, et al.
Publicado: (2021)

A bispecific, crosslinking lectibody activates cytotoxic T cells and induces cancer cell death
por: Rosato, Francesca, et al.
Publicado: (2022)

Microarray analysis of RNA extracted from formalin-fixed, paraffin-embedded and matched fresh-frozen ovarian adenocarcinomas
por: Fedorowicz, Grazyna, et al.
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_r7gdp7qc98vtvgim2ej995ef85